RT Journal Article
SR Electronic
T1 Prevalence and clinical correlates of COVID-19 outbreak among health care workers in a tertiary level hospital in Delhi
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.21.20159301
DO 10.1101/2020.07.21.20159301
A1 Ankit Khurana
A1 GP Kaushal
A1 Rishi Gupta
A1 Vansh Verma
A1 Kabir Sharma
A1 Manmohan Kohli
YR 2020
UL http://medrxiv.org/content/early/2020/07/24/2020.07.21.20159301.abstract
AB In this study, we summarize the epidemiological characteristics of COVID-19 outbreak among Healthcare workers (HCWs) in a tertiary care hospital and compared various parameters and preventive measures taken by positive HCWs to a comparable cohort of COVID negative HCWs. 52.1% of COVID-19 positive HCWs showed symptoms of which only three needed hospitalization possibly due to a younger cohort of HCWs who got infected (35.9 ± 9.3 years). Findings of present study found some protective role of full course prophylactic hydroxychloroquine as compared to a control group (p=0.021) and use of N95 masks over others (p<0.001). Our results did not show any added protection with the use of prophylactic Vitamin C, D, Zinc, or betadine gargles. We also observed outbreak control with increased awareness, near universal testing, PPE provision, sanitization drive, and promoting social distancing among HCWs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received or usedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute ethical and scientific committee, BSAMCHAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata associated with a paper is available, and data can be accessed after writing to the corresponding author